Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Daniel G. Healy; Mario Falchi; Sean S. O’Sullivan; Vincenzo Bonifati; Alexandra Durr; Susan Bressman; Alexis Brice; Jan Aasly; Cyrus P. Zabetian; Stefano Goldwurm; Joaquim J. Ferreira; Eduardo Tolosa; Denise M. Kay; Christine Klein; David R. Williams; Connie Marras; Anthony E. Lang; Zbigniew K. Wszołek; José Berciano; Anthony H.V. Schapira; Timothy Lynch; Kailash P. Bhatia; Thomas Gasser; Andrew J. Lees; Nicholas Wood

doi:10.1016/s1474-4422(08)70117-0

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

UK Medical Research Council; UK Parkinson's Disease Society; UK Brain Research Trust; Internationaal Parkinson Fonds; Volkswagen Foundation; National Institutes of Health: National Institute of Neurological Disorders and Stroke and National Institute of Aging; Udall Parkinson's Disease Centre of Excellence; Pacific Alzheimer Research Foundation Centre; Italian Telethon Foundation; Fondazione Grigioni per il Morbo di Parkinson; Michael J Fox Foundation for Parkinson's Research; Safra Global Genetics Consortium; US Department of Veterans Affairs; French Agence Nationale de la Recherche.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Healy et al. (2008) studied this question.

synapsesocial.com/papers/69e0754fb116c10c7ec11e0f https://doi.org/10.1016/s1474-4422(08)70117-0

View Full Paper

Ask AI

Bookmark

Share

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Ask about this paper

Abstract

Discussion

Cite This Study

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading